An agency bellwether, PHCG is hoping to return to growth after a tame 2012, its CEO said this week.
Pfizer redesigned its annual review as part of a rolling rebranding exercise aimed at personalizing the company, emphasizing corporate responsibility and stressing the scientific prowess of a giant better known for its marketing.
Patient access to pharmaceuticals is a tale of two worlds—affordability has improved for the majority, while the minority is hampered by cost, distribution and red tape. To provide marketers with a well-rounded perspective, MM&M presents this e-book chock full of key insights. Click here to access it.